Yaoxiang Sun

2.1k total citations · 2 hit papers
23 papers, 1.6k citations indexed

About

Yaoxiang Sun is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Yaoxiang Sun has authored 23 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Genetics. Recurrent topics in Yaoxiang Sun's work include Extracellular vesicles in disease (14 papers), MicroRNA in disease regulation (6 papers) and Mesenchymal stem cell research (4 papers). Yaoxiang Sun is often cited by papers focused on Extracellular vesicles in disease (14 papers), MicroRNA in disease regulation (6 papers) and Mesenchymal stem cell research (4 papers). Yaoxiang Sun collaborates with scholars based in China, Ghana and United States. Yaoxiang Sun's co-authors include Wenrong Xu, Hui Shi, Hui Qian, Xu Zhang, Bin Zhang, Yongmin Yan, Zhaoji Pan, Peipei Wu, Tieliang Ma and Cheng Ji and has published in prestigious journals such as ACS Nano, Scientific Reports and Cell Death and Disease.

In The Last Decade

Yaoxiang Sun

22 papers receiving 1.6k citations

Hit Papers

Human Mesenchymal Stem Cell Derived Exosomes Alleviate Ty... 2018 2026 2020 2023 2018 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaoxiang Sun China 17 1.2k 570 331 229 189 23 1.6k
Jia Cao China 19 1.6k 1.3× 544 1.0× 215 0.6× 271 1.2× 338 1.8× 35 2.2k
Shilong Han China 16 700 0.6× 327 0.6× 300 0.9× 397 1.7× 124 0.7× 37 1.3k
Min Wu China 23 947 0.8× 523 0.9× 131 0.4× 110 0.5× 195 1.0× 97 1.8k
Basak Icli United States 18 1.2k 1.0× 952 1.7× 119 0.4× 149 0.7× 153 0.8× 27 1.9k
Zhao Zheng China 22 629 0.5× 233 0.4× 214 0.6× 412 1.8× 209 1.1× 46 1.4k
Rongfeng Shi China 12 636 0.5× 255 0.4× 322 1.0× 431 1.9× 115 0.6× 24 1.1k
Qianwen Shang China 13 636 0.5× 221 0.4× 236 0.7× 90 0.4× 116 0.6× 22 1.1k
Zhenzhen Jiang China 18 692 0.6× 354 0.6× 80 0.2× 77 0.3× 217 1.1× 61 1.4k
Hyuck Hoon Kwon South Korea 26 595 0.5× 162 0.3× 188 0.6× 194 0.8× 157 0.8× 58 2.1k
Seema Dangwal Germany 18 684 0.6× 538 0.9× 94 0.3× 187 0.8× 158 0.8× 27 1.2k

Countries citing papers authored by Yaoxiang Sun

Since Specialization
Citations

This map shows the geographic impact of Yaoxiang Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaoxiang Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaoxiang Sun more than expected).

Fields of papers citing papers by Yaoxiang Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaoxiang Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaoxiang Sun. The network helps show where Yaoxiang Sun may publish in the future.

Co-authorship network of co-authors of Yaoxiang Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Yaoxiang Sun. A scholar is included among the top collaborators of Yaoxiang Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaoxiang Sun. Yaoxiang Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Yaoxiang, et al.. (2025). Engineered MEVs for photoreceptor-targeted delivery of USP25 to alleviate diabetic retinopathy. Journal of Nanobiotechnology. 23(1). 575–575.
2.
Zhou, Xinyi, et al.. (2025). Small extracellular vesicles: the origins, current status, future prospects, and applications. Stem Cell Research & Therapy. 16(1). 184–184. 5 indexed citations
3.
Wang, Min, Dakai Yang, Peipei Wu, et al.. (2024). A Dual Role of Mesenchymal Stem Cell Derived Small Extracellular Vesicles on TRPC6 Protein and Mitochondria to Promote Diabetic Wound Healing. ACS Nano. 18(6). 4871–4885. 26 indexed citations
4.
Zhang, Ling, et al.. (2024). Lipidomic analysis of serum exosomes identifies a novel diagnostic marker for type 2 diabetes mellitus. Laboratory Medicine. 55(6). 724–731. 2 indexed citations
5.
Hu, Yu‐Yan, Hui Shi, Wenrong Xu, et al.. (2024). Mesenchymal stem cell-derived extracellular vesicles ameliorate renal interstitial fibrosis via the miR-13474/ADAM17 axis. Scientific Reports. 14(1). 17703–17703. 10 indexed citations
6.
Zhu, Junyan, et al.. (2024). Emerging role of extracellular vesicles in diabetic retinopathy. Theranostics. 14(4). 1631–1646. 17 indexed citations
7.
Huang, Jin, et al.. (2023). Ectopic pregnancy adjacent to iliac vessels managed successfully by minimally invasive treatment using local methotrexate injection: An extremely rare case and literature review. Journal of Gynecology Obstetrics and Human Reproduction. 52(10). 102691–102691. 4 indexed citations
9.
Wang, Min, Peipei Wu, Wenhui Liu, et al.. (2022). Skin cell-derived extracellular vesicles: a promising therapeutic strategy for cutaneous injury. Burns & Trauma. 10. tkac037–tkac037. 20 indexed citations
10.
Li, Yu, Tieliang Ma, Wenrong Xu, et al.. (2022). Small extracellular vesicles isolation and separation: Current techniques, pending questions and clinical applications. Theranostics. 12(15). 6548–6575. 224 indexed citations breakdown →
11.
Q, Yu, Min Wang, Yu Li, et al.. (2022). Stem Cell-Based Therapy for Diabetic Foot Ulcers. Frontiers in Cell and Developmental Biology. 10. 812262–812262. 55 indexed citations
12.
Tao, Qing, Zhiguo Wang, Jianfeng Shi, et al.. (2022). Tea Ingredients Have Anti-coronavirus Disease 2019 (COVID-19) Targets Based on Bioinformatics Analyses and Pharmacological Effects on LPS-Stimulated Macrophages. Frontiers in Nutrition. 9. 875765–875765. 2 indexed citations
13.
Shi, Hui, Min Wang, Yaoxiang Sun, et al.. (2021). Exosomes: Emerging Cell-Free Based Therapeutics in Dermatologic Diseases. Frontiers in Cell and Developmental Biology. 9. 736022–736022. 37 indexed citations
14.
Sun, Yaoxiang, et al.. (2021). The Utility of Exosomes in Diagnosis and Therapy of Diabetes Mellitus and Associated Complications. Frontiers in Endocrinology. 12. 756581–756581. 64 indexed citations
15.
Shi, Hui, Yaoxiang Sun, Cheng Ji, et al.. (2021). 3,3′-Diindolylmethane Promotes Gastric Cancer Progression via β-TrCP-Mediated NF-κB Activation in Gastric Cancer-Derived MSCs. Frontiers in Oncology. 11. 603533–603533. 17 indexed citations
16.
Wang, Min, et al.. (2021). Calcium Channels: Noteworthy Regulators and Therapeutic Targets in Dermatological Diseases. Frontiers in Pharmacology. 12. 702264–702264. 21 indexed citations
17.
Sun, Yaoxiang, Hui Shi, Siqi Yin, et al.. (2018). Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction. ACS Nano. 12(8). 7613–7628. 354 indexed citations breakdown →
18.
Zhang, Rongxue, Lei Yin, Bin Zhang, et al.. (2018). Resveratrol improves human umbilical cord-derived mesenchymal stem cells repair for cisplatin-induced acute kidney injury. Cell Death and Disease. 9(10). 965–965. 42 indexed citations
19.
Shi, Hui, Zhaoji Pan, Aihua Gong, et al.. (2017). 3,3′-Diindolylmethane stimulates exosomal Wnt11 autocrine signaling in human umbilical cord mesenchymal stem cells to enhance wound healing. Theranostics. 7(6). 1674–1688. 91 indexed citations
20.
Wu, Lijun, Xu Zhang, Bin Zhang, et al.. (2016). Exosomes derived from gastric cancer cells activate NF-κB pathway in macrophages to promote cancer progression. Tumor Biology. 37(9). 12169–12180. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026